Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat
Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs.
Tony Piscopio describes the year that Boulder-based Array BioPharma Inc. was acquired by Pfizer Inc. (NYSE: PFE) as transformative for the
Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc, advancing breakthrough science.
Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc, advancing breakthrough science for the di
Pfizer Inc. has entered into a definitive merger agreement with Array BioPharma, in which Pfizer will acquire Array BioPharma for $48 per share in cash, leading to a total enterprise value
On Octo, the Food and Drug Administration approved encorafenib (Braftovi, Array BioPharma Inc, a wholly owned subsidiary of Pfizer) with
Search ARRAY BIOPHARMA INC business contracts filed with the Securities and Exchange Commission.
Inc.) for subcutaneous injection for all the adult indications as Array BioPharma Inc, a wholly owned subsidiary of Pfizer) with
Comments